Phase II Study of Weekly Paclitaxel/Nab-Paclitaxel, Pembrolizumab, and Mirabegron for Recurrent Ovarian Cancer

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.